Thursday, 6 March 2014

North American Home Healthcare Market worth $130.4 Billion By 2017

Home care or domiciliary care is supportive care provided by the licensed healthcare professionals in the home itself. It ensures that the activities of daily living (ADL’s) are met. More accurately it is referred as the Home healthcare or formal care which distinguishes it from non-medical care, custodial care or private duty care which is basically given by persons who are not licensed medical personals. Home healthcare services may include short-term nursing, therapeutic, rehabilitative, and assistive home healthcare. Specifically speaking, home healthcare may also include occupational and physical therapy, speech therapy, and even skilled nursing.


                                           Source: https://www-edc.eng.cam.ac.uk/

The healthcare market is witnessing a tremendous growth over the few years. The most significant trend witnessed in the healthcare market recently is the shift of treatment from hospitals to home in order to reduce expensive hospital expenditure. This shift has been opening up new major opportunities for the healthcare market. Various factors contributing to this are innovations in healthcare market, easy availability, aging demographics and increasing chronic diseases. These factors are driving the U.S. healthcare market significantly which has the largest share of the global healthcare market in terms of revenue. All these factors have made home healthcare a lucrative market for various companies. However there are few factors like cut in Medicare payments to home health agencies and risk to the safety of home healthcare workers which are limiting the growth of this market.


                                            Source: http://www.cepro.com/images/

According to a new market research report by MarketsandMarkets, the home healthcare market has been witnessing a surge as it offers heavy cost advantage to the patients by reducing their hospital expenditure. The North America home healthcare market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. The report analyzes and studies the major market drivers, restraints, and opportunities in North America.

In the report the home healthcare market has been broadly segmented on the basis of products, services, and tele-health. Factors like prominent chronic diseases and increasing healthcare cost, are fueling the growth of this market. According to the report, the U.S. is dominating the North American home healthcare market and is expected to maintain that position in the coming five years owing to the rising aging population, increasing chronic diseases, technological developments for various home use applications (home healthcare therapeutic equipment, home healthcare testing monitoring devices and mobility assist & other devices), positive response to home-based devices, increasing awareness, and insurance coverage in the country. The prominent home healthcare service provider companies are Apria Healthcare Group (U.S.), Amdisys Inc. (U.S.) and Gentiva Health Service Inc. (U.S.)  while key home healthcare product manufacturing companies are Alere, Inc. (U.S.), Fresenius Se & Co KGAa (Germany), GE Healthcare (U.K), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Philips Healthcare (The Netherlands), and Roche Holdings (Switzerland).

The report can be referred here:



No comments:

Post a Comment